SS
COLL icon

Steve Schonfeld’s Collegium Pharmaceutical COLL Stock Holding History

Steve Schonfeld’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,932
Closed -$414K – 2294
2025
Q4 		$414K Buy
+8,932
New +$374K ﹤0.01% 1466
2022
Q4 		– Sell
-18,000
Closed -$289K – 2648
2022
Q3 		$289K Buy
+18,000
New +$317K ﹤0.01% 2109
2019
Q1 		– Sell
-130,800
Closed -$2.25M – 1075
2018
Q4 		$2.25M Sell
130,800
-75,000
-36% -$1.28M 0.09% 299
2018
Q3 		$3.03M Buy
+205,800
New +$3.65M 0.13% 209
2017
Q3 		– Sell
-42,931
Closed -$537K – 623
2017
Q2 		$537K Buy
42,931
+25,425
+145% +$251K 0.06% 378
2017
Q1 		$176K Buy
+17,506
New +$260K 0.02% 554

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Steve Schonfeld's COLL Position: Q1 2026 in Review

Steve Schonfeld sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 8,932 shares — an estimated $414K sold.

Steve Schonfeld first reported a position in COLL in Q1 2017 and held it in 6 quarters. The position peaked at $3.03M in Q3 2018. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Steve Schonfeld reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 8,932 Collegium Pharmaceutical shares in Q1 2026, an estimated $414K.
  • Steve Schonfeld first reported a position in Collegium Pharmaceutical in Q1 2017 and held it in 6 quarters.
  • Steve Schonfeld's Collegium Pharmaceutical position peaked at $3.03M in Q3 2018.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.